0001388295 2026-01-01 2026-03-31 0001388295 2026-05-15 0001388295 2026-03-31 0001388295 2025-12-31 0001388295 us-gaap:NonrelatedPartyMember 2026-03-31 0001388295 us-gaap:NonrelatedPartyMember 2025-12-31 0001388295 us-gaap:RelatedPartyMember 2026-03-31 0001388295 us-gaap:RelatedPartyMember 2025-12-31 0001388295 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001388295 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2025-12-31 0001388295 2025-01-01 2025-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001388295 us-gaap:CommonStockMember 2024-12-31 0001388295 ONEI:CommonStockLiabilityMember 2024-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2024-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001388295 us-gaap:RetainedEarningsMember 2024-12-31 0001388295 2024-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001388295 us-gaap:CommonStockMember 2025-12-31 0001388295 ONEI:CommonStockLiabilityMember 2025-12-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-12-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001388295 us-gaap:RetainedEarningsMember 2025-12-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001388295 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001388295 ONEI:CommonStockLiabilityMember 2025-01-01 2025-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-01-01 2025-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001388295 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001388295 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001388295 ONEI:CommonStockLiabilityMember 2026-01-01 2026-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2026-01-01 2026-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001388295 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001388295 us-gaap:CommonStockMember 2025-03-31 0001388295 ONEI:CommonStockLiabilityMember 2025-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2025-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001388295 us-gaap:RetainedEarningsMember 2025-03-31 0001388295 2025-03-31 0001388295 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001388295 us-gaap:CommonStockMember 2026-03-31 0001388295 ONEI:CommonStockLiabilityMember 2026-03-31 0001388295 ONEI:SeriesBOneConvertiblePreferredStockLiabilityMember 2026-03-31 0001388295 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001388295 us-gaap:RetainedEarningsMember 2026-03-31 0001388295 ONEI:OEMAgreementMember 2024-10-08 0001388295 ONEI:OEMAgreementMember 2025-01-01 2025-12-31 0001388295 ONEI:OEMAgreementMember 2026-01-01 2026-03-31 0001388295 ONEI:OEMAgreementMember 2026-03-31 0001388295 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-01-01 2026-03-31 0001388295 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-03-31 0001388295 us-gaap:ConvertibleNotesPayableMember 2026-01-01 2026-03-31 0001388295 ONEI:SubscriptionLicenseAndSoftwareRevenueMember 2026-01-01 2026-03-31 0001388295 ONEI:SubscriptionLicenseAndSoftwareRevenueMember 2025-01-01 2025-03-31 0001388295 ONEI:ProfessionalServicesMember 2026-01-01 2026-03-31 0001388295 ONEI:ProfessionalServicesMember 2025-01-01 2025-03-31 0001388295 ONEI:OEMSolutionMember 2026-01-01 2026-03-31 0001388295 ONEI:OEMSolutionMember 2025-01-01 2025-03-31 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2026-01-01 2026-03-31 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2025-01-01 2025-03-31 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2026-03-31 0001388295 ONEI:FormerChiefFinancialOfficerMember ONEI:RowlandDayMember 2025-12-31 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2026-01-01 2026-03-31 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2025-01-01 2025-03-31 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2026-03-31 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SaulLealMember 2025-12-31 0001388295 srt:ChiefExecutiveOfficerMember 2026-02-02 2026-02-02 0001388295 srt:ChiefExecutiveOfficerMember 2026-02-02 0001388295 srt:ChiefExecutiveOfficerMember 2026-03-31 0001388295 srt:DirectorMember ONEI:PromissoryNoteAgreementMember 2026-01-27 0001388295 srt:DirectorMember ONEI:PromissoryNoteAgreementMember 2026-02-01 2026-02-01 0001388295 srt:DirectorMember ONEI:PromissoryNoteAgreementMember 2026-03-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2025-01-01 2025-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-01-01 2024-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2025-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2024-12-31 0001388295 ONEI:SeniorSecuredPromissoryNotesPayableMember ONEI:RowlandDayMember 2026-03-31 0001388295 ONEI:RowlandDayMember 2025-10-31 2025-10-31 0001388295 ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember 2025-10-31 0001388295 ONEI:RowlandDayMember us-gaap:CommonStockMember 2025-10-31 0001388295 srt:MinimumMember ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember 2025-10-31 0001388295 srt:MaximumMember ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember 2025-10-31 0001388295 srt:MinimumMember ONEI:RowlandDayMember us-gaap:CommonStockMember 2025-10-31 0001388295 srt:MaximumMember ONEI:RowlandDayMember us-gaap:CommonStockMember 2025-10-31 0001388295 ONEI:RowlandDayMember 2026-03-26 2026-03-26 0001388295 ONEI:RowlandDayMember 2026-01-01 2026-03-31 0001388295 ONEI:RowlandDayMember 2026-03-31 0001388295 ONEI:RowlandDayMember 2026-03-26 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2026-03-31 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2026-01-01 2026-03-31 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-12-31 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2026-03-31 0001388295 srt:DirectorMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001388295 2025-12-25 0001388295 ONEI:ThreeInvestorsMember us-gaap:ConvertibleNotesPayableMember 2024-12-01 2024-12-31 0001388295 ONEI:ThreeInvestorsMember us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001388295 ONEI:ThreeInvestorsMember us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-12-31 0001388295 us-gaap:ConvertibleNotesPayableMember 2026-03-31 0001388295 us-gaap:ConvertibleNotesPayableMember 2026-01-01 2026-03-31 0001388295 us-gaap:ConvertibleNotesPayableMember 2025-12-31 0001388295 ONEI:PurchaseAgreementsMember 2025-10-31 2025-10-31 0001388295 ONEI:PurchaseAgreementsMember 2025-10-31 0001388295 srt:MaximumMember ONEI:PurchaseAgreementsMember 2025-10-31 2025-10-31 0001388295 srt:MinimumMember ONEI:PurchaseAgreementsMember 2025-10-31 2025-10-31 0001388295 ONEI:TwoPromissoryNoteAgreementsMember 2026-02-11 0001388295 ONEI:TwoPromissoryNoteAgreementsMember 2026-02-11 2026-02-11 0001388295 ONEI:ThreeMonthsThereafterMember ONEI:TwoPromissoryNoteAgreementsMember 2026-02-11 2026-02-11 0001388295 ONEI:PromissoryNoteOneMember 2025-09-11 2025-09-11 0001388295 ONEI:PromissoryNoteOneMember 2025-09-11 0001388295 ONEI:PromissoryNoteOneMember 2026-01-01 2026-03-31 0001388295 ONEI:PromissoryNoteOneMember 2026-03-31 0001388295 ONEI:PromissoryNoteOneMember 2025-12-31 0001388295 ONEI:PromissoryNoteTwoMember 2025-10-13 2025-10-13 0001388295 ONEI:PromissoryNoteTwoMember 2025-10-13 0001388295 ONEI:PromissoryNoteTwoMember 2026-01-01 2026-03-31 0001388295 ONEI:PromissoryNoteTwoMember 2026-03-31 0001388295 ONEI:PromissoryNoteTwoMember 2025-12-31 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-03-26 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-03-26 2026-03-26 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-01-01 2026-03-31 0001388295 ONEI:TwoInvestorsMember ONEI:SecuredPromissoryNoteAgreementsMember 2026-03-31 0001388295 ONEI:PromissoryNoteMember 2026-03-31 0001388295 ONEI:PromissoryNoteMember 2025-12-31 0001388295 ONEI:SeriesAConvertiblePreferredStockMember 2026-03-31 0001388295 ONEI:SeriesAConvertiblePreferredStockMember 2026-01-01 2026-03-31 0001388295 ONEI:SeriesAConvertiblePreferredStockMember 2025-12-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-01-01 2026-03-31 0001388295 ONEI:SeriesBOnePreferredStockMember 2023-09-30 2023-09-30 0001388295 srt:ChiefExecutiveOfficerMember ONEI:SeriesBOnePreferredStockMember 2026-03-09 2026-03-09 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-03-09 0001388295 ONEI:SeriesBOnePreferredStockMember 2026-03-09 2026-03-09 0001388295 ONEI:SeriesBTwoPreferredStockMember 2026-03-31 0001388295 ONEI:SeriesBTwoPreferredStockMember 2025-12-31 0001388295 ONEI:ConvertiblePromissoryNotesMember 2026-01-01 2026-03-31 0001388295 ONEI:ConvertiblePromissoryNotesMember 2026-03-31 0001388295 ONEI:AccountsPayableSettlementMember 2026-01-01 2026-03-31 0001388295 ONEI:AccountsPayableSettlementMember 2026-03-31 0001388295 ONEI:ConsultantMember 2026-01-01 2026-03-31 0001388295 ONEI:SeveralConsultantAgreementsMember 2026-01-01 2026-03-31 0001388295 ONEI:ConsultantAgreementOneMember 2026-01-01 2026-01-01 0001388295 ONEI:ConsultantAgreementOneMember 2026-01-01 2026-03-31 0001388295 ONEI:SixMonthTermConsultantAgreementMember 2025-12-18 2025-12-18 0001388295 ONEI:SixMonthTermConsultantAgreementMember 2026-01-01 2026-03-31 0001388295 ONEI:ConsultantAgreementTwoMember 2025-08-01 2025-08-01 0001388295 ONEI:ConsultantAgreementTwoMember 2025-12-15 2025-12-15 0001388295 ONEI:ConsultantAgreementTwoMember 2025-01-01 2025-12-31 0001388295 ONEI:ConsultantAgreementTwoMember 2026-01-01 2026-03-31 0001388295 ONEI:ConsultantAgreementThreeMember 2025-08-01 2025-08-01 0001388295 ONEI:ConsultantAgreementThreeMember 2025-01-01 2025-12-31 0001388295 ONEI:ConsultantAgreementThreeMember 2026-01-01 2026-03-31 0001388295 ONEI:SeveralConsultantAgreementsMember 2026-03-31 0001388295 ONEI:AdvisorOneMember 2026-03-30 2026-03-30 0001388295 ONEI:AdvisorOneMember 2026-01-01 2026-03-31 0001388295 ONEI:AdvisorTwoMember 2025-11-10 2025-11-10 0001388295 ONEI:AdvisorTwoMember 2026-01-01 2026-03-31 0001388295 ONEI:AdvisorThreeMember 2025-10-01 2025-10-01 0001388295 ONEI:AdvisorThreeMember 2026-01-01 2026-03-31 0001388295 ONEI:AdvisorFourMember 2024-12-01 2024-12-01 0001388295 ONEI:AdvisorFourMember 2026-01-01 2026-03-31 0001388295 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001388295 ONEI:EmployeesMember us-gaap:EmployeeStockOptionMember 2026-02-23 2026-02-23 0001388295 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember 2026-03-31 0001388295 us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember 2026-03-31 0001388295 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2026-03-31 0001388295 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2026-03-31 0001388295 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2026-03-31 0001388295 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2026-03-31 0001388295 us-gaap:WarrantMember 2025-12-31 0001388295 us-gaap:WarrantMember 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputSharePriceMember 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputPriceVolatilityMember 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember us-gaap:MeasurementInputExpectedTermMember 2026-03-31 0001388295 us-gaap:EmployeeStockOptionMember 2025-12-31 0001388295 ONEI:ChiefExecutiveOfficerAndDirectorMember 2024-12-31 0001388295 us-gaap:SubsequentEventMember ONEI:MasterResellerAgreementMember 2026-04-08 0001388295 ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember us-gaap:SubsequentEventMember 2026-04-10 2026-04-10 0001388295 ONEI:RowlandDayMember ONEI:SeriesBOnePreferredStockMember us-gaap:SubsequentEventMember 2026-04-10 0001388295 ONEI:SecuredPromissoryNotesMember us-gaap:SubsequentEventMember 2026-04-07 2026-04-07 iso4217:USD shares iso4217:USD shares pure false --12-31 Q1 0001388295

10-Q true 2026-03-31 2026 false 000-56565 ONEMETA INC. NV 20-5150818 450 South 400 East Suite 200 Bountiful UT 84010 (702) 550-0122 None. Yes Yes Non-accelerated Filer true true false false 38890943

60124

4584

50186

22508

50000

83209

94845

243519

121937

1680

1843

1680

1843

245199

123780

1038469

926889

528698

133845

117000

97000

117000

97000

25000

3140000

940000

450000

250000

450000

250000

716695 380321

303624

316196

6319486

3044251

1387612

6319486

4431863

0.001

50000000

0.001

5000000

2068

0.001

8619420

862

0.001

500000000

38890943

38891

1474605

527889

1129920

37944158

38480044

-46662725

-43355771

-6074287

-4308083

245199

123780

180117

128518

65560

114557

128518

406311

349586

1937753

481320

2011

8725

154367 218420

2500442

1058051

-2385885

-929533

5304

926373

24682

-921069

-24682

-3306954

-954215

-0.09

-0.03

-0.09

-0.03

38890943

37790943

38890943

37790943

2068

8619420

862

37790943

37791

36792679

-39516154

-2684820

83901

-954215

2068

8619420

862

37790943

37791

36876580

-40470369

-3555134

2068

8619420

862

38890943

38891

527889

38480044

-43355771

-4308083

950000 950000 1129920 1129920 946716 946716

130557

30723

252834

-3306954

2068

8619420

862

38890943

38891

1474605

1129920

37944158

-46662725

-6074287

-3306954

-954215

30723

130557

83901

946716 1129920

688678

163

27678

38550

50000

-11636

-591

131664

263976

294853

43040

-84 74682

-12572

-90000

-32378

-616575

9000

6000

200000

190000

200000

250000

80000

187082

25000

150000

87918

443000

55540

-173575

4584

215816

60124

42241

107126

42526

20084 82529 700000 252834 100000

Note 1. Basis of Presentation The accompanying unaudited interim financial statements of OneMeta Inc. (“we”, “our”, “OneMeta” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the financial statements and notes thereto contained in the Company’s fiscal 2025 financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for our interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosure contained in the financial statements for fiscal 2025, have been omitted. OneMeta was originally incorporated as Promotions on Wheels Holdings, Inc., a Nevada corporation, on July 3, 2006. On December 26, 2008, the name of the Company was changed to Blindspot Alert, Inc. On September 11, 2009, the Company’s name was changed to WebSafety, Inc. On March 23, 2021, the Company’s name was changed to VeriDetx Corp. On June 8, 2021, the Company’s name was changed to WebSafety, Inc. On July 10, 2022, the Company’s name was changed to OneMeta AI. On June 20, 2023, the Company’s name was changed to OneMeta Inc.

Note 2. Summary of Significant Accounting Policies Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of stock-based compensation, fair value measurement and long-term customer contracts. Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less. Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, past experience, review of customer profiles and the aging of receivable balances. As of March 31, 2026 and December 31, 2025, there was $1,160 of allowance for credit losses. Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions. Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates. Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> Subscription and license We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. OEM solution The Company provides Over-the-phone, consecutive AI Translation Service (“VerbumCall SDK”) that uses WebSocket connections to provide an AI service designed to facilitate effortless communication across languages within the platforms. This product leverages advanced AI capabilities to provide consecutive audio translation, ensuring that both patrons and agents experience conversations without the need for additional steps or complicated setups. The Company has multiple performance obligations in the customer contract with inContact. The Company is to generate revenue through the following sources: sale of OEM Solution software and professional services, which consist of implementation, configuration, custom development, optimization, training and technical support services of the OEM Solution. VerbumAgentis On March 31, 2025, the Company entered into a reseller and distribution agreement to provide software development kit (SDK) to the reseller to use and/or resell to their customers. The Company will provide the reseller with a VerbumAgentis communication platform and an encryption key to install on their computer system and servers. In return, the reseller is to pay an initial one-time paid-up fee of $500,000. VerbumAgentis is a standalone communication platform with core capabilities such as chat-based interaction, transcription, and multilingual simultaneous interpretation for voice-to-voice customer interactions. It includes real-time bidirectional communication and integrations. While live translation leverages underlying language models (SDK), the core platform delivers independent value even without SDK execution for each interaction. VerbumAgentis is installed on client’s servers that they control. The Company is to deliver and install the VerbumAgentis platform on the customers’ server and provide translation services on an as requested basis by the end customers. The customer benefits from the VerbumAgentis platform as a standalone system once installed on their infrastructure. Further, the translation services and other per usage items outlined in the contract are obligations that arise when those services are initiated by the customer. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and professional service revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zxM74XyD8p83" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250331_zvrJSiEMb5q9" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionLicenseAndSoftwareRevenueMember_zHObaZuI6AU5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Subscription, license and software revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">755</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ProfessionalServicesMember_zbuBrNV8rJdk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,375</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,518</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OEMSolutionMember_zsmLFgHHBfVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">OEM Solution usage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwt6xPkB2YDc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">180,117</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">128,518</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. On October 8, 2024, the Company entered into an OEM Agreement to provide OEM Solutions hosting consisting of over-the-phone consecutive AI language translation solutions. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. The Company identified three separate performance obligations within the contract. The performance obligations are OEM Solution service, professional services and technical support. The OEM Solution revenue is recognized based on a per-minute rate while the professional services and technical support revenue is recognized based on a per hour rate. The Company expects the $700,000 credit to be used mainly by OEM Solution and professional services. The Company recognized $448,804 of the credit during the year ended December 31, 2025. As of March 31, 2026, the Company expects to recognize all the unsatisfied performance obligations as revenue in the following quarter. During the three months ended March 31, 2026, the Company recognized $110,696 as revenue from the credit. As of March 31, 2026, the deferred revenue balance was $140,500. During the period ended March 31, 2026, the Company recorded additional $98,125 of deferred revenue. As of March 31, 2026 and December 31, 2025, the deferred revenue balance was $303,624 and $316,196, respectively. Stock-Based Compensation All stock-based awards to employees and non-employee contractors, including any grants of stock and stock options, are measured at fair value at the grant date and recognized over the relevant vesting period in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Stock based awards to non-employees are recognized as a selling, general and administrative expense over the period of performance. Such awards are measured at fair value at the date of grant. In addition, for awards that vest immediately, the awards are measured at fair value and recognized in full at the grant date. Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined by using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2026, the Company’s potentially dilutive shares, which were not included in the calculation of net loss per share, included warrants to purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zym9wXyYeQX2" title="Warrants outstanding">9,650,000 common shares, options to purchase <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zWx0aVUOlAw9" title="Options outstanding">5,365,000 common shares, conversion of Series B-1 shares to purchase <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBOnePreferredStockMember_zmPhUTOKZKJ3" title="Conversion shares">94,813,620 common shares, conversion of Series A shares to purchase <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesAPreferredStockMember_zH6A61EsbMch" title="Conversion shares">2,585 common shares, and the conversion of the convertible notes to <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zrIJSKpzH59b" title="Conversion shares">34,338,135 common shares. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations As of March 31, 2026 and 2025, reflected in the accompanying statement of operations. Segments Reporting The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment. Recent Accounting Pronouncements Disaggregation of Income Statement Expenses In November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires specified information about certain costs and expenses be disclosed in the notes to the financial statements, including the expense caption on the face of the income statement in which they are disclosed, in addition to a qualitative description of remaining amounts not separately disaggregated. Entities will also be required to disclose their definition of “selling expenses” and the total amount in each annual period. The standard is effective for the Company for annual periods beginning January 1, 2027 and for interim periods beginning January 1, 2028, with updates applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures. Credit Losses In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides updates related to CECL guidance for certain short-term receivables. The ASU is effective for fiscal years beginning after December 15, 2025. We adopted ASU No. 2025-05 during the year ended December 31, 2026, with no material impact to the Company’s financial statements or results of operations.

Use of Estimates In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates in the accompanying financial statements involving the valuation of stock-based compensation, fair value measurement and long-term customer contracts.

Cash and Cash Equivalents Cash equivalents include all highly liquid investments with original maturities of three months or less.

Accounts Receivable Accounts receivable are comprised of unsecured amounts due from customers. The Company carries its accounts receivable at their face amounts less an allowance for credit losses. The allowance for credit losses is recognized based on management’s estimate of likely losses per year, past experience, review of customer profiles and the aging of receivable balances. As of March 31, 2026 and December 31, 2025, there was $1,160 of allowance for credit losses.

1160

Related Parties The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash and accounts payable. The carrying values of these financial instruments approximate their respective fair values as they are short-term in nature or carry interest rates that approximate market rates.

Revenue Recognition The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts With Customers, which was adopted on January 1, 2018 using the modified retrospective method, with no impact to the Company’s comparative financial statements. Revenues are recognized when control of the promised goods or services is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the contract with a customer</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Determination of the transaction price</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation </td></tr> </table> Subscription and license We enter into revenue arrangements in which a customer may purchase a combination of subscriptions, consulting services, training and education. Fully hosted subscription services (“SaaS”) allow customers to access hosted software during the contractual term without taking possession of the software. We recognize revenue ratably over the contractual service term for hosted services that are priced based on a committed number of transactions where the delivery and consumption of the benefit of the services occur evenly over time, beginning on the date the services associated with the committed transactions are first made available to the customer and continuing through the end of the contractual service term. Over-usage fees and fees based on the actual number of transactions are billed in accordance with contract terms as these fees are incurred and are included in the transaction price of an arrangement as variable consideration. Revenue based on per-minute or per-word basis, where invoicing is aligned to the pattern of performance, customer benefit and consumption, are typically accounted for utilizing the “as-invoiced” practical expedient. Revenue for subscriptions sold as a fee per period is recognized ratably over the contractual term as the customer simultaneously receives and consumes the benefit of the underlying service. Licenses for software may be purchased as a subscription for a fixed period of time or based on usage. Revenue from licenses is recognized at the point in time the software is available to the customer, provided all other revenue recognition criteria are met, and classified as revenue on our Statements of Operations. Our interpretation or translation services fees are based on a per-minute or per-word basis, are typically accounted for utilizing the “as-invoiced” practical expedient. Our services are comprised primarily of fees related to training, and education for certain licenses that are recognized at a point in time. Training and education revenues are recognized as the services are performed. OEM solution The Company provides Over-the-phone, consecutive AI Translation Service (“VerbumCall SDK”) that uses WebSocket connections to provide an AI service designed to facilitate effortless communication across languages within the platforms. This product leverages advanced AI capabilities to provide consecutive audio translation, ensuring that both patrons and agents experience conversations without the need for additional steps or complicated setups. The Company has multiple performance obligations in the customer contract with inContact. The Company is to generate revenue through the following sources: sale of OEM Solution software and professional services, which consist of implementation, configuration, custom development, optimization, training and technical support services of the OEM Solution. VerbumAgentis On March 31, 2025, the Company entered into a reseller and distribution agreement to provide software development kit (SDK) to the reseller to use and/or resell to their customers. The Company will provide the reseller with a VerbumAgentis communication platform and an encryption key to install on their computer system and servers. In return, the reseller is to pay an initial one-time paid-up fee of $500,000. VerbumAgentis is a standalone communication platform with core capabilities such as chat-based interaction, transcription, and multilingual simultaneous interpretation for voice-to-voice customer interactions. It includes real-time bidirectional communication and integrations. While live translation leverages underlying language models (SDK), the core platform delivers independent value even without SDK execution for each interaction. VerbumAgentis is installed on client’s servers that they control. The Company is to deliver and install the VerbumAgentis platform on the customers’ server and provide translation services on an as requested basis by the end customers. The customer benefits from the VerbumAgentis platform as a standalone system once installed on their infrastructure. Further, the translation services and other per usage items outlined in the contract are obligations that arise when those services are initiated by the customer. Disaggregation of revenues The Company disaggregates revenue between subscription and license revenue and professional service revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zxM74XyD8p83" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250331_zvrJSiEMb5q9" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionLicenseAndSoftwareRevenueMember_zHObaZuI6AU5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Subscription, license and software revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">755</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ProfessionalServicesMember_zbuBrNV8rJdk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,375</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,518</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OEMSolutionMember_zsmLFgHHBfVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">OEM Solution usage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwt6xPkB2YDc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">180,117</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">128,518</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Deferred Revenue Deferred revenue includes service and support contracts and represents the undelivered performance obligation of agreements that are typically for one year or less. On October 8, 2024, the Company entered into an OEM Agreement to provide OEM Solutions hosting consisting of over-the-phone consecutive AI language translation solutions. Upon execution of the agreement, the Company received $700,000 from NICE as a credit balance for future service. The Company identified three separate performance obligations within the contract. The performance obligations are OEM Solution service, professional services and technical support. The OEM Solution revenue is recognized based on a per-minute rate while the professional services and technical support revenue is recognized based on a per hour rate. The Company expects the $700,000 credit to be used mainly by OEM Solution and professional services. The Company recognized $448,804 of the credit during the year ended December 31, 2025. As of March 31, 2026, the Company expects to recognize all the unsatisfied performance obligations as revenue in the following quarter. During the three months ended March 31, 2026, the Company recognized $110,696 as revenue from the credit. As of March 31, 2026, the deferred revenue balance was $140,500. During the period ended March 31, 2026, the Company recorded additional $98,125 of deferred revenue. As of March 31, 2026 and December 31, 2025, the deferred revenue balance was $303,624 and $316,196, respectively.

500000

The Company disaggregates revenue between subscription and license revenue and professional service revenue. Schedule of Disaggregation of Revenue <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260101__20260331_zxM74XyD8p83" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20250101__20250331_zvrJSiEMb5q9" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SubscriptionLicenseAndSoftwareRevenueMember_zHObaZuI6AU5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Subscription, license and software revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">755</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ProfessionalServicesMember_zbuBrNV8rJdk" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,375</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">128,518</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OEMSolutionMember_zsmLFgHHBfVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">OEM Solution usage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,987</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zwt6xPkB2YDc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">180,117</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">128,518</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

755

168375

128518

10987

180117

128518

700000

448804

110696

140500

98125

303624

316196

Stock-Based Compensation All stock-based awards to employees and non-employee contractors, including any grants of stock and stock options, are measured at fair value at the grant date and recognized over the relevant vesting period in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Stock based awards to non-employees are recognized as a selling, general and administrative expense over the period of performance. Such awards are measured at fair value at the date of grant. In addition, for awards that vest immediately, the awards are measured at fair value and recognized in full at the grant date.

Basic and Diluted Loss Per Share Basic loss per common share is computed by dividing the net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined by using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2026, the Company’s potentially dilutive shares, which were not included in the calculation of net loss per share, included warrants to purchase <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zym9wXyYeQX2" title="Warrants outstanding">9,650,000 common shares, options to purchase <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zWx0aVUOlAw9" title="Options outstanding">5,365,000 common shares, conversion of Series B-1 shares to purchase <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBOnePreferredStockMember_zmPhUTOKZKJ3" title="Conversion shares">94,813,620 common shares, conversion of Series A shares to purchase <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesAPreferredStockMember_zH6A61EsbMch" title="Conversion shares">2,585 common shares, and the conversion of the convertible notes to <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zrIJSKpzH59b" title="Conversion shares">34,338,135 common shares. Accordingly, the number of weighted average shares outstanding, as well as the amount of net loss per share are presented for basic and diluted per share calculations As of March 31, 2026 and 2025, reflected in the accompanying statement of operations.

9650000

5365000

94813620

2585

34338135

Segments Reporting The Company manages its operations as a single segment for the purpose of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company using information about combined net income from operations. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.

Recent Accounting Pronouncements Disaggregation of Income Statement Expenses In November 2024, the FASB issued Accounting Standards Update No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires specified information about certain costs and expenses be disclosed in the notes to the financial statements, including the expense caption on the face of the income statement in which they are disclosed, in addition to a qualitative description of remaining amounts not separately disaggregated. Entities will also be required to disclose their definition of “selling expenses” and the total amount in each annual period. The standard is effective for the Company for annual periods beginning January 1, 2027 and for interim periods beginning January 1, 2028, with updates applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its disclosures. Credit Losses In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides updates related to CECL guidance for certain short-term receivables. The ASU is effective for fiscal years beginning after December 15, 2025. We adopted ASU No. 2025-05 during the year ended December 31, 2026, with no material impact to the Company’s financial statements or results of operations.

Note 3. Going Concern These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of March 31, 2026, the Company had not yet achieved profitable operations and expects to incur further losses in the development of its business, all of which raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. The Company is actively seeking funding through debt and equity offerings. Management cannot be certain that such events or a combination thereof can be achieved.

Note 4. Related Party Transactions Expense paid on the Company’s behalf During the three months ended March 31, 2026 and 2025, former chief financial officer paid $<span id="xdx_909_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_ztcqH6pZ3Pi6" title="Expenses paid on the company's behalf">0 and $<span id="xdx_900_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zC0hO6kpx6m8" title="Expenses paid on the company's behalf">82,529 of expenses on the Company’s behalf and was repaid $<span id="xdx_908_ecustom--RepaymentsOfExpensesToRelatedParty_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zDbPl8Hrjy9h" title="Repayments of expenses to related party">0 and $<span id="xdx_90A_ecustom--RepaymentsOfExpensesToRelatedParty_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zee3MAe57Xlg" title="Repayments of expenses to related party">0, respectively. As of March 31, 2026 and December 31, 2025, the balance owed to former chief financial officer $<span id="xdx_90F_eus-gaap--OtherLiabilitiesCurrent_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zJRbo3gTotdd" title="Balance owed"><span id="xdx_90A_eus-gaap--OtherLiabilitiesCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--TitleOfIndividualAxis__custom--FormerChiefFinancialOfficerMember_zcmRWuowhGHc" title="Balance owed">0. During the three months ended March 31, 2026 and 2025, the chief executive officer paid $<span id="xdx_90E_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zViE9e9pP9M5" title="Expenses paid on the company's behalf">20,084 and $<span id="xdx_900_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_z7VBUIeGVKe7" title="Expenses paid on the company's behalf">0 of expenses on the Company’s behalf and was repaid $<span id="xdx_90E_ecustom--RepaymentsOfExpensesToRelatedParty_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zpg8MTkWQbNc" title="Repayments of expenses to related party">0 and $<span id="xdx_903_ecustom--RepaymentsOfExpensesToRelatedParty_c20250101__20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zWcTPxoqLEi4" title="Repayments of expenses to related party">0, respectively. As of March 31, 2026 and December 31, 2025, the balance owed to chief executive officer $<span id="xdx_903_eus-gaap--OtherLiabilitiesCurrent_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zIzyjHOXhI26" title="Balance owed">20,084 and $<span id="xdx_902_eus-gaap--OtherLiabilitiesCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_ztZc2YOQBr5" title="Balance owed">0, respectively. Accruals As of March 31, 2026, the accrued related party salary and accrued interest expense was $117,000 and $13,826, respectively. As of December 31, 2025, the accrued related party salary and accrued interest expense was $97,000 and $12,307, respectively. During the period ended March 31, 2026, the board approved a health stipend for the Company’s Chief Executive Officer, Saul Leal, in the amount of $<span id="xdx_908_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20260101__20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zFaG4OxgjMPl" title="Health stipend amount per month">2,800 per month with a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zhUdJMEQTL2a" title="Cumulative interest rate">5% cumulative interest on the unpaid balance. The stipend and interest were retroactively applied back to commencing of service in July 2022. As of March 31, 2026, the Company accrued $<span id="xdx_908_eus-gaap--AccruedEmployeeBenefitsCurrent_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zH2y0gCiyoB3" title="Accrued stipend">126,000 for the stipend and $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SaulLealMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_ziVQO7lJ5NTk" title="Accrued interest for stipend">12,792 for the accrued interest. Advances On February 2, 2026, the Company’s Chief Executive Officer advanced the Company $25,000 to be used for operating expenditures. The advance is due on demand and accrues interest at a rate of 14%. As of March 31, 2026, the advance and accrued interest balance was $25,000 and $547, respectively. Secure promissory note On January 27, 2026, the Company entered into a promissory note agreement for $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20260127__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zLEYvCAYQ1g3" title="Promissory note">80,000 with Roy Chestnutt, Company’s Director. The Company recognized debt discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260127__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zTCz3jDEVzCa" title="Debt discount">1,612 at the issuance of the note. Pursuant to the agreement, the interest on the promissory note shall equal to <span id="xdx_90D_eus-gaap--SharesIssued_iI_pid_c20260127__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z3d1ENvRILbj" title="Restricted common stock issuable of interest">16,000 shares of restricted common stock of the Company. Both the principal balance and the shares are payable on February 1, 2026. As of February 1, 2026, the Company paid the principal balance of $<span id="xdx_900_eus-gaap--DebtInstrumentRepaidPrincipal_c20260201__20260201__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zavcEMSNayma" title="Principal balance paid">80,000 and issued the <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20260201__20260201__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zqQO2jx6423g" title="Common stock issued for interest">16,000 common shares for the accrued interest. As of March 31, 2026, the principal balance of the promissory note was $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pid_c20260331__us-gaap--TypeOfArrangementAxis__custom--PromissoryNoteAgreementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zMYg5l68NrNi" title="Principal balance">0. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the years ended December 2025 and 2024, the Company entered into multiple secured promissory notes agreements with the Company’s former Chief Executive Officer, Rowland Day, for total proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_za3AEW1p8P85" title="Expenses paid on the company's behalf"><span id="xdx_90E_eus-gaap--ProceedsFromRelatedPartyDebt_c20240101__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zR4ycaxSfXw6" title="Expenses paid on the company's behalf">883,500. The notes were secured by the assets of the Company and accrued interest at the rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_z3vTccX8SGr2" title="Interest rate"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zZj1BX2Xejfh" title="Interest rate">14% per annum. During the year ended December 31, 2025 and as part of the separation agreement with Rowlan Day, the Company repaid the outstanding principal balance of $<span id="xdx_907_eus-gaap--DebtInstrumentRepaidPrincipal_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zkvwJKUakix7" title="Principal balance paid">802,450 and the accrued interest of $<span id="xdx_90B_eus-gaap--InterestPaid_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zaP0URjs6prk" title="Interest paid">101,225. As of March 31, 2026 and December 31, 2025, the related party senior secured promissory notes payable principal balance was $<span id="xdx_909_eus-gaap--NotesPayable_iI_c20260331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zLJOJbtvLgt4" title="Notes payable principal balance">0 and $<span id="xdx_902_eus-gaap--NotesPayable_iI_c20251231__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zmM2NNTMiDGh" title="Notes payable principal balance">0, respectively, with accrued interest of $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_znjOhUucdgr1" title="Accrued interest">0 and $<span id="xdx_90D_eus-gaap--InterestPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredPromissoryNotesPayableMember_zqGJgxYKUMu5" title="Accrued interest">0, respectively. Settlement Agreement Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. In connection with his resignation, the Company made payments to Mr. Day in the amount of $917,966 in satisfaction of outstanding loans and reimbursable credit card balances owed to him and a payment in the amount of $408,486 for accrued salary. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of up to <span id="xdx_90A_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zexzrQxhPdJh" title="Stock issued during the period, shares">4,309,710 shares of the Company’s Series B-1 Preferred Stock and <span id="xdx_907_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaO6JCTnaIZ2" title="Number of shares authorized for repurchase">307,647 shares of common stock, at per-share prices ranging from $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_zdk0dDgF9iD5" title="Share price">0.605-$<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_znXP26mvCmh6" title="Share price">0.66 for the preferred shares and $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_zYHUsEPwSZRa" title="Share price">0.055-$<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_zdW9D5dNBz0g" title="Share price">0.06 for the common shares, depending on the repurchase date. The purchase was to occur on or around March 27, 2026 (the “Expiration Date”). On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. During the period ended March 31, 2026, the Company accrued the $100,000 extension fee and paid $150,000 as a deposit on the stock re-purchase to Rowland. Additionally, through issuance of two notes dated March 26, 2026 (Note 6), $700,000 was wire directly by the noteholder to Rowland as a deposit on the stock re-purchase. Convertible notes payable During the year ended December 31, 2025 and the period ended March 31, 2026, the Company issued a series of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zx3p8MYQEbgk" title="Interest rate"><span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20251231__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVHqJ1qtHb6" title="Interest rate">0% interest convertible notes payable to a director, a director nominee and two relatives of a the director nominee in exchange for $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20260101__20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zSDlAXRI54I" title="Proceeds from convertible notes"><span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_c20250101__20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_za6GaxMlJfo8" title="Proceeds from convertible notes">450,000. The convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) <span id="xdx_902_eus-gaap--DebtConversionDescription_c20260101__20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zeyoE53POfP7" title="Convertible price, description">the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date. During the period ended March 31, 2026, the Company and four noteholders amended the terms of the convertible note agreements to retroactively accrue interest on their notes from the effective date of the agreements on a rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zo5QwwN2W8W7" title="Debt effective percentage">10%. During the period ended March 31, 2026, the Company recorded and accrued interest expense on the convertible notes in the amount of $<span id="xdx_90A_eus-gaap--InterestExpense_c20260101__20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zpKGHukVtFDh" title="Accrued interest expense">22,726. Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates of the convertible notes. As of March 31, 2026 and December 31, 2025, the convertible notes payable principal balance was $<span id="xdx_903_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVZEo9Dcpyre" title="Convertible note payable related party">450,000 and $<span id="xdx_908_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zMMa3KbEazKh" title="Convertible note payable related party">250,000, respectively, and the accrued interest was $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zibozaaOTmJ3" title="Accrued interest">22,726 and $<span id="xdx_90A_eus-gaap--InterestPayableCurrent_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zAEsdQaVShG3" title="Accrued interest">0, respectively. The Company calculated imputed interest on the zero percent convertible notes using an interest rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20260101__20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zLgy2nDwWNg3" title="Interest rate">14% and recorded to additional paid-in-capital. As of March 31, 2026 and December 31, 2025, the Company recorded imputed interest of $<span id="xdx_90B_ecustom--ImputeInterest_iI_c20260331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zfPaBp85HVBc" title="Impute interest">3,414 and $<span id="xdx_906_ecustom--ImputeInterest_iI_c20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__srt--TitleOfIndividualAxis__srt--DirectorMember_ztcAgBuW9eg2" title="Impute interest">30,359, respectively. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of March 31, 2026. As March 31, 2026, the matured convertible notes would potentially be converted into 1,299,934 common shares. Schedule of Convertible Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260331_zPIaSCPy84Ck" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20251225_zqriWWCQ2kv6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_40E_ecustom--ConvertibleNotesPayableRelatedPartyCurrent_iI_maCDz2aq_zWW4tpgzTL4b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Convertible notes payable, relate party</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">450,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">250,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebt_iTI_mtCDz2aq_zLjEvvix2MAj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total convertible notes payable, relate party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleDebtCurrent_iNI_di_zAME215NDeLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(450,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebtNoncurrent_iI_zS1VU3WyX46b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term convertible notes payable, relate party, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

82529

0 0

20084

0 0

20084

117000

13826

97000

12307

2800

0.05

126000

12792

25000

0.14

25000

547

80000

1612

16000

80000

16000

883500

0.14

802450

101225

917966

408486

4309710 307647

0.605

0.66

0.055

0.06

100000

150000

700000

450000

the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

0.10

22726

450000

250000

22726

0.14

3414 30359

1299934

Schedule of Convertible Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260331_zPIaSCPy84Ck" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20251225_zqriWWCQ2kv6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_40E_ecustom--ConvertibleNotesPayableRelatedPartyCurrent_iI_maCDz2aq_zWW4tpgzTL4b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Convertible notes payable, relate party</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">450,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">250,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebt_iTI_mtCDz2aq_zLjEvvix2MAj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total convertible notes payable, relate party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConvertibleDebtCurrent_iNI_di_zAME215NDeLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(450,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebtNoncurrent_iI_zS1VU3WyX46b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term convertible notes payable, relate party, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

450000 250000

450000

250000

450000

250000

Note 5. Convertible Notes Payable In December 2024, the Company issued convertible notes payable to three investors in exchange for $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20241201__20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zjiTDy8Yd8W1" title="Proceeds from convertible notes">650,000. During the year ended December 31, 2025, the Company issued <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zgnyEY4gMEa4" title="Interest rate">0% interest convertible notes payable to three investors in exchange for $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zZmvybToLDg3" title="Proceeds from convertible notes">290,000. convertible notes mature six months following that date of issuance and do not accrue interest. The notes are convertible into common shares as follows: (i) on the next equity financing conversion: the principal balance on each note will convert into shares upon the closing of the next equity financing. The number of conversion shares the Company issues upon such conversion will equal the quotient obtained by dividing (x) the outstanding principal balance under each converting note on the closing date of the next equity financing by (y) the applicable conversion price of the product of <span id="xdx_90F_eus-gaap--DebtConversionDescription_c20250101__20251231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThreeInvestorsMember_zBSkmKKWbl54" title="Convertible price, description">(x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date. During the period ended March 31, 2026, the Company and four noteholders amended the terms of the convertible note agreements to retroactively accrue interest on their notes from the effective date of the agreements on a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20260331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zTUX55KyhhSi" title="Debt effective percentage">10%. During the period ended March 31, 2026, the Company recorded and accrued interest expense on the convertible notes in the amount of $16,027. Company evaluated the conversion feature and determined that no embedded derivative liability existed on the issuance dates of the convertible notes. As of March 31, 2026 and December 31, 2025, the convertible notes payable principal balance was $940,000 and $940,000, respectively, and the accrued interest was $16,027 and $0, respectively. The Company calculated imputed interest on the zero percent convertible notes using an interest rate of 14% and recorded to additional paid-in-capital. As of March 31, 2026 and December 31, 2025, the Company recorded imputed interest of $27,309 and $119,040, respectively. The Company evaluated the conversion feature and determined that, since the conversion price is fixed, no embedded derivative liability existed as of March 31, 2026. As March 31, 2026, the matured convertible notes would potentially be converted into <span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgGhWWYwQ2Th" title="Common stock capital shares reserved for future issuance">5,538,201 common shares. On November 3, 2025, the Company entered into a Convertible Notes Agreement and a Warrant Purchase Agreements (the “Purchase Agreements”), dated as of October 31, 2025, with two investors (the “Holders”) for their purchase of (i) 14% convertible secured promissory notes of the Company in the aggregate original principal amount of $2,000,000 payable on October 31, 2028 (the “Notes”) with a fixed conversion price of $0.08 and (ii) 5-year warrants to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20251031__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementsMember_zeJqJZmYYFGd" title="Warrants to purchase common stock">6,000,000 shares of the Company’s common stock at an exercise price of $0.08. The proceeds are to used to repay all amounts outstanding under those certain 14% secured promissory notes and credit card balances to the former President of the Company in the amounts of $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_c20251031__20251031__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementsMember_zbhJps5pd8pg" title="Promissory notes repaid">917,966 and $<span id="xdx_90F_eus-gaap--RepaymentsOfOtherDebt_c20251031__20251031__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementsMember_zVwm1GjJygdd" title="payment of credit card balances">408,486, respectively. The remainder of the proceeds were used for working capital and general corporate purposes. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders. On February 11, 2026, the Company entered into two Promissory Note Agreements (the “Additional Notes”) with the Holders for an additional $200,000. The interest on the promissory note shall equal to <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20260211__20260211__us-gaap--TypeOfArrangementAxis__custom--TwoPromissoryNoteAgreementsMember_zzGu3QGsbrec" title="Common stock issuable for interest">125,000 shares of common stock of the Company for each note. Both the principal balance and the shares are payable on February 26, 2026. Per the agreement, If the loans were note repaid when matured, the Company will issue an additional <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20260211__20260211__us-gaap--TypeOfArrangementAxis__custom--TwoPromissoryNoteAgreementsMember_zXnUHVk3ozw1" title="Stock issued during period shares additional new issues">125,000 shares of common stock for each note and <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20260211__20260211__us-gaap--TypeOfArrangementAxis__custom--TwoPromissoryNoteAgreementsMember__us-gaap--AwardDateAxis__custom--ThreeMonthsThereafterMember_zpWC3kpAwLw5" title="Common stock issuable on default">125,000 shares every three months thereafter. On March 17, 2026, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Amendment” or “Amended and Restated Note”) with the Holders. Pursuant to the Amended and Restated Note, the Company and the Holders combined the Existing Notes and the Additional Notes in their entirety under the terms of the Amended and Restated Note. Under the Amended and Restated Note, the maturity date of the Existing Notes was amended on March 26, 2026. The Company recognized amortization on the debt discount of $<span id="xdx_905_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20260101__20260331__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zg1rM6Iv1K3h" title="Amortization on debt discount">612,338 during the period ended March 31, 2026. As of March 31, 2026 and December 31, 2025, the principal balance of the notes was $2,200,000 and $2,000,000. As of March 31, 2026 The unamortized debt discount was $0. Schedule of Convertible Notes Payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260331_zDQD1NSCT6Nd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20251231_zJ4NOeLy8OUk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_401_ecustom--ConvertibleNotesPayableGross_iI_zEyVB5X2Ewrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Convertible notes payable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">3,140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">2,327,612</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_z8JedPMIfnOl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,327,612</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ConvertibleNotesPayablesCurrent_iNI_di_zIzLZ2IEGTFh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(940,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleLongTermNotesPayable_iI_zVEGIplrjiVh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term convertible notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,387,612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

650000

290000

(x) 100% less the discount of 25% and (y) the lowest per share purchase price of the equity securities issued in the next equity financing; and/or (ii) corporate transaction conversion: at the closing of a major corporate transaction, the note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of such note on the closing of such corporate transaction by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the closing date of the corporate transaction; and/or (iii) at any time on or after the maturity date, each note will convert into that number of conversion shares equal to the quotient obtained by dividing (x) the outstanding principal balance of the note on the date of such conversion by (y) the applicable conversion price of the product of (x) 100% less the discount of 25% and (y) the volume weighted average trading price on the date that is ten days immediately prior to the maturity date.

0.10

16027

940000

16027 0

0.14

27309 119040

5538201

0.14

2000000

0.08

P5Y

6000000

0.08

0.14

917966

408486

200000

125000

612338

2200000

2000000

Schedule of Convertible Notes Payable <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260331_zDQD1NSCT6Nd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20251231_zJ4NOeLy8OUk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_401_ecustom--ConvertibleNotesPayableGross_iI_zEyVB5X2Ewrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Convertible notes payable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">3,140,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">2,327,612</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_z8JedPMIfnOl" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,140,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,327,612</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ConvertibleNotesPayablesCurrent_iNI_di_zIzLZ2IEGTFh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(940,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleLongTermNotesPayable_iI_zVEGIplrjiVh" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term convertible notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,387,612</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

3140000 2327612

3140000

2327612

3140000 940000

1387612

Note 6. Promissory Notes On September 11, 2025, the Company entered into a Promissory Note for a principal amount of $353,050 with the Company receiving cash proceeds of $300,000. The Company recognized debt discount of $53,050 at the issuance of the notes. The note matures on August 30, 2026, and bears a one-time interest of 12% or $42,366. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date. During the period ended March 31, 2026, the Company repaid $172,995 of the principal balance The Company recognized amortization on the debt discount of $13,263 during the period ended March 31, 2026. As of March 31, 2026 and December 31, 2025, the principal balance of the note was $180,056 and $353,050. On October 13, 2025, the Company entered into a Promissory Note for a principal amount of $76,550 with the Company receiving cash proceeds of $70,000. The Company recognized debt discount of $18,550 at the issuance of the notes. The note matures on August 15, 2026 and bears a one-time interest of 15% or $13,282. Any amount of principal or interest which is not paid when due shall bear interest at the rate of 22% per annum from the due date. Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date. During the period ended March 31, 2026, the Company repaid $14,087 of the principal balance The Company recognized amortization on the debt discount of $5,565 during the period ended March 31, 2026. As of March 31, 2026 and December 31, 2025, the principal balance of the note was $62,463 and $76,550. On March 26, 2026, the Company entered Secured Promissory Note Agreements with two investors for their purchase of (i) <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zISMZIlkjOK3" title="Interest rate">14% secured promissory notes of the Company in the aggregate original principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zzbYQDdFnygk" title="Principal amount">700,000 payable on April 17, 2026 and (ii) <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zWQUkEc7eU3d" title="Warrants term">5-year warrants to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_z6OuH5tEwoqh" title="Warrants to purchase common stock">3,300,000 shares of the Company’s common stock at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_z6UL1bAAfYk1" title="Exercise price">0.08. The proceeds were paid directly to Rowland Day as part of the Stock Purchase Agreement. Should the Company default on repayment for the note in full by the maturity date, the Common shall issue to the holders a total of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260326__20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zT7y1tYs7Wh7" title="Number of shares issued">8,750,000 shares of the Company’s common stock. The Company’s obligations under the Notes are secured by a security interest in certain property granted by the Company for the benefit of Holders pursuant to the terms of a Security Agreement dated October 31, 2025, between the Company and the Holders and a Patent Security Agreement dated October 31, 2025, between the Company and Holders. The warrants had a relative fair value of $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20260326__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zxglO7dEiRN2" title="Fair value of warrants">252,834, which was recorded as a discount on the note. The Company recognized amortization on the debt discount of $<span id="xdx_90E_eus-gaap--AmortizationOfDebtDiscountPremium_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zNE7Shi1cfk5" title="Amortization of debt discount">57,462 during the period ended March 31, 2026 on the promissory notes. As of March 31, 2026, the principal balance of the note was $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--TypeOfArrangementAxis__custom--SecuredPromissoryNoteAgreementsMember__srt--TitleOfIndividualAxis__custom--TwoInvestorsMember_zqbpiloX8DM7" title="Principal balance">700,000. Schedule of Promissory Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zz6wzIa6TFDk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zKEISE3Y2Epg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_408_ecustom--PromissoryNotePayableNet_iI_pp0p0_zjSaiILPmsFf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Promissory notes payable, net</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">716,695</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">380,321</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NotesPayable_iTI_pp0p0_mtNPz031_zlNBAd4KRtP3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total Promissory notes payable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">716,695</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">380,321</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayableCurrent_iNI_pp0p0_di_zvSZ7PgVsYz6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(716,695</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(380,321</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--LongTermNotesPayable_iI_pp0p0_zYC3bgjZFRP3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term Promissory notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of March 31, 2026, the unamortized debt discount was $225,823. As of December 31, 2025, the Company had unamortized debt discount of $49,279.

353050

300000

53050

2026-08-30

0.12

42366

0.22

Additionally, in the event of default, the holder may convert all or any part of the outstanding and unpaid amount of this note into shares of Company’s common stock with a discount rate of 35% on the lowest trading price of the common stock during the ten trading days prior to the conversion date

172995

13263

180056

353050

76550

70000

18550

2026-08-15

0.15

13282

0.22

14087

5565

62463

76550

0.14

700000

P5Y

3300000

0.08

8750000

252834

57462

700000

Schedule of Promissory Notes Payable Related Party <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zz6wzIa6TFDk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31, 2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zKEISE3Y2Epg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_408_ecustom--PromissoryNotePayableNet_iI_pp0p0_zjSaiILPmsFf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify; padding-bottom: 1pt">Promissory notes payable, net</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">716,695</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">380,321</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NotesPayable_iTI_pp0p0_mtNPz031_zlNBAd4KRtP3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total Promissory notes payable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">716,695</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">380,321</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayableCurrent_iNI_pp0p0_di_zvSZ7PgVsYz6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Less: current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(716,695</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(380,321</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--LongTermNotesPayable_iI_pp0p0_zYC3bgjZFRP3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Long term Promissory notes payable, net of current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 716695 380321

716695

380321

716695

380321

225823

49279

Note 7. Equity The Company is currently authorized to issue up to 500,000,000 shares of common stock with a par value of $0.001. In addition, The Company is authorized to issue 50,000,000 shares of preferred stock with a par value of $0.001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors. Common Stock As of March 31, 2026 and December 31, 2025, there were 38,890,943 and 38,890,943 shares issued and outstanding, respectively. Preferred Stock Series A Convertible Preferred Stock Our board of directors designated <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zTarhbKbyUYc" title="Preferred stock, shares authorized">2,068 shares of our preferred stock as Series A Convertible Preferred Stock (“Series A”) with a par value of $<span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zeSgMvnX97qh" title="Preferred stock, par value">0.001. Series A has liquidation and dividend preferences. <span id="xdx_902_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zWsgAf0kXeg4" title="Preferred stock, convertible terms">Each share of Series A has voting rights equal to the amount of shares of common stock into which the Series A is convertible. Each share of Series A is convertible on a 1 to 1.25 common share basis. As of each of March 31, 2026 and December 31, 2025, there were <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zAJ2raUNXagl" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zzqI2LGNMmya" title="Preferred stock, shares outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zeXk8dlggn03" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zBv13ZweAm3d" title="Preferred stock, shares outstanding">2,068 shares of Series A issued and outstanding. Series B-1 Convertible Preferred Stock Our board of directors designated 8,619,420 shares of our preferred stock as Series B-1 Convertible Preferred Stock (“Series B-1”) with a par value of $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zQuAojBOlJ6f" title="Preferred stock, par value">0.001. Series B-1 has liquidation and dividend preferences. Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock into which the Series B-1 are convertible. <span id="xdx_907_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zUkC3rbe4fFg" title="Preferred stock, conversion terms">Each share of Series B-1 is convertible on a 1 to 11 common share basis. On September 30, 2023, the Articles of Incorporation of the Company were amended to remove the redemption right of the Series B-1. The Company’s Articles of Incorporation require <span id="xdx_905_ecustom--PercentageOfOutstandingVotes_dp_uPure_c20230930__20230930__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_z4l6COFocull" title="Outstanding votes percent">51% of the outstanding votes of the Series B-1 to amend or repeal any incorporation documents that would alter the rights or preferences of Series B-1, alter the authorized number of shares of the series, create or issue any classes of preferred stock senior to the Series B-1, amend the company’s bylaws, or enter into a transaction that would result in a change in control. As of March 31, 2026 and December 31, 2025, there are <span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zVcfy86X0IMf" title="Preferred stock, shares outstanding"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zgLYmFvKkTu5" title="Preferred stock, shares outstanding">8,619,420 shares of Series B-1 issued and outstanding. Effective October 31, 2025, Rowland W. Day II resigned from his positions as President, Chief Financial Officer, Secretary, Chief Legal Officer, and as a member of the Board of Directors of the Company. In connection with his resignation, the Company agreed to enter into a Stock Repurchase Agreement providing for repurchase by the Company from the Trust of up to <span id="xdx_90A_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zQPWjiNGb9U2" title="Stock issued during the period, shares">4,309,710 shares of the Company’s Series B-1 Preferred Stock and <span id="xdx_907_esrt--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pid_c20251031__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3oSByyZLWG1" title="Number of shares authorized for repurchase">307,647 shares of common stock, at per-share prices ranging from $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_zem6zFJQaaj2" title="Share price">0.605-$<span id="xdx_905_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_z6v2QbcESzlc" title="Share price">0.66 for the preferred shares and $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MinimumMember_zBdbRAfIjrE7" title="Share price">0.055-$<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember__srt--RangeAxis__srt--MaximumMember_zzdPMKsGdHG" title="Share price">0.06 for the common shares, depending on the repurchase date. On March 26, 2026, the Company entered into an amendment to the Stock Repurchase Agreement pursuant to which the Expiration Date was extended to April 10, 2026. As part of the extension of the settlement date, the Company is to pay an additional $100,000 to Rowland as an extension fee. During the period ended March 31, 2026, the Company accrued the $100,000 extension fee and paid $150,000 as a deposit on the stock re-purchase to Rowland. Additionally, $700,000 was wire directly by the noteholder to Rowland as a deposit on the stock re-purchase. As of March 31, 2026, $<span id="xdx_901_ecustom--AdjustmentsToAdditionalPaidInCapitalPreferredStockRepurchaseDeposit_c20260101__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zcFFnNPPRF46" title="Preferred shares liability">950,000 was recorded as Series B-1 convertible Preferred shares liability on the statement of stockholder’s equity. On March 9, 2026, the board of directors approved the issuance of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260309__20260309__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_ztsR3Yt8nb83" title="Shares issued for bounus">800,000 share of Series B-1 Convertible Preferred Stock to Mr. Leal as a bonus. The <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260309__20260309__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zkWh9Yj0aKad" title="Shares issued for bounus">800,000 shares of Series B-1 convertible preferred stock valued at the at-converted value of $<span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20260309__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zjAvLUWtnZOj" title="Converted price per share">0.13 per share with a fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260309__20260309__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember_zaI8Qaxissaa" title="Value of shares issued for bonus">1,129,920. As of March 31, 2026, the Series B-1 convertible Preferred shares were not issued to the equity holders and as such, the shares were recorded as Series B-1 convertible Preferred liability on the statement of stockholder’s equity. Series B-2 Convertible Preferred Stock Our board of directors designated 3,107,438 shares of our preferred stock as Series B-2 Convertible Preferred Stock (“Series B-2”) with a par value of $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_zuR5OlrG8m5h" title="Preferred stock, par value">0.001. On May 1, 2023, the Articles of Incorporation of the Company were amended such that no Series B-2 shares are authorized. Series B-2 have no liquidation or dividend preferences. Each share of Series B-2 has voting rights equal to the amount of shares of common stock the Series B-2 is convertible to and is convertible on a 1 to 1 common share basis and shall automatically be converted into common shares up the Public Offering Closing. As of March 31, 2026 and December 31, 2025, there are <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_zHQHmY1a6OGf" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBTwoPreferredStockMember_zIieZRXDFyN3" title="Preferred stock, shares outstanding">no shares of Series B-2 issued and outstanding. Common Stock Liability Common stock to be issued for cash During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zszIbiq4KoQh" title="Number of shares issued for cash">4,722,224 shares of common stock for $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE4Mb3CFXZA9" title="Value of shares issued for cash">650,000 cash. As of March 31, 2026, $50,000 of the proceeds was recorded as subscription receivable. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended March 31, 2026, total amount of shares payable and total value recorded as common stock liability issued for cash was 4,722,224 and $650,000, respectively. Common stock to be issued for interest During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesMember_z2kxkJdPK8Q3" title="Number of shares issued for interest">516,000 shares of common stock in lieu of interest on convertible and promissory notes with a fair value of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pid_c20260101__20260331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesMember_z0GcZb8bxYXl" title="Value of shares issued for interest">81,364. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended March 31, 2026, total amount of shares payable and total value recorded as common stock liability issued for interest on notes was 516,000 and $81,364, respectively. Common stock to be issued for accounts payable settlement During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20260101__20260331__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--AccountsPayableSettlementMember_zDS0wQmZdBad" title="Number of shares issued to settle accounts payable">100,000 shares of common stock to settle an accounts payable balance with a fair value of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pid_c20260101__20260331__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--AccountsPayableSettlementMember_zxlDaBiW46w" title="Value of shares issued to settle accounts payable">10,696. The Company recorded a net gain on the settlement of $<span id="xdx_90F_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pid_c20260101__20260331__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--AccountsPayableSettlementMember_zdeQt2393G43" title="Gain on settlement">5,304. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended March 31, 2026, total amount of shares payable and total value recorded as common stock liability issued for accounts payable settlement was 100,000 and $10,696, respectively. Common stock to be issued for service During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260331__srt--TitleOfIndividualAxis__custom--ConsultantMember_zYjYdVyvey8i" title="Number of shares issued for serivce">40,000 shares to a consultant for service rendered during the period. The shares had a fair value of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pid_c20260101__20260331__srt--TitleOfIndividualAxis__custom--ConsultantMember_zxkD8PppAS21" title="Value of shares issued for serivce">5,528, which was recorded as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended March 31, 2026, the Company entered into several consultant agreements where the Company granted the issuance of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--SeveralConsultantAgreementsMember_z99a8cEVRJM9" title="Number of shares issued for serivce">1,110,238 common shares to the consultant. The shares had a fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pid_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--SeveralConsultantAgreementsMember_z1WC24dBy6Q" title="Value of shares issued for serivce">181,993, which was recorded as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. On January 1, 2026, the Company entered into a consultant agreement where the consultant will receive <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260101__20260101__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementOneMember_zurEKq9tFaY5" title="Issuance of common shares">10,000 common shares on a monthly basis beginning on the effective date of the agreement. During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementOneMember_zAX93C6oyZi1" title="Issuance of common shares">30,000 common shares to the consultant. The shares had a fair value of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementOneMember_zxd6BWQcM427" title="Stock based compensation">4,509, which was recorded as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. On December 18, 2025, the Company entered into a six month term consultant agreement where the consultant will receive <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20251218__20251218__us-gaap--TypeOfArrangementAxis__custom--SixMonthTermConsultantAgreementMember_zngDaKZnD26e" title="Issuance of common shares">7,000 common shares on a monthly basis beginning on the effective date of the agreement. During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--SixMonthTermConsultantAgreementMember_zQZVs5DEx0Z9" title="Issuance of common shares">21,000 common shares to the consultant. The shares had a fair value of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--SixMonthTermConsultantAgreementMember_zdy4sxXlQo21" title="Stock based compensation">3,156, which was recorded as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250801__20250801__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zqJSOa2Qnepa" title="Issuance of common shares">7,000 common shares on a monthly basis beginning on the effective date of the agreement. On December 15,2025, the Company entered into an amendment to the consultant agreement to increase the number of monthly common shares to <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20251215__20251215__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zJMjbCSA4e08" title="Issuance of common shares">14,000 common shares per month beginning on January 1, 2026. In 2025, the Company granted the issuance of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zwbf730GYpP6" title="Issuance of common shares">35,000 common shares to the consultant. During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zX95x0R5KvZf" title="Issuance of common shares">42,000 common shares to the consultant. The shares had a fair value of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementTwoMember_zkJA61MAtpg2" title="Stock based compensation">6,313, which was recorded as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. On August 1, 2025, the Company entered into a consultant agreement where the consultant will receive <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250801__20250801__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_zHQ74677F2ml" title="Shares issuable for services per month">7,000 common shares on a monthly basis beginning on the effective date of the agreement. In 2025, the Company granted the issuance of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20250101__20251231__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_z2QIbA9YXw98" title="Issuance of common shares">35,000 common shares to the consultant. During the period ended March 31, 2026, the Company granted the issuance of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_z8jBSIfmwJ9k" title="Number of shares issued for serivce">21,000 common shares to the consultant. The shares had a fair value of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20260101__20260331__us-gaap--TypeOfArrangementAxis__custom--ConsultantAgreementThreeMember_z423pWGsEXkk" title="Fair value of shares issued for serivce">3,156, which was recorded as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. During the period ended March 31, 2026, total amount of shares payable and total value recorded as common stock liability issued for service was 1,264,238 and $204,656, respectively. As of March 31, 2026, the total common stock liability for common stock and vested restricted stock was 8,830,462 shares of common stock. Restricted Common Stock On March 30, 2026, the Company granted the issuance of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20260330__20260330__srt--TitleOfIndividualAxis__custom--AdvisorOneMember_zcbgXpnMuwM8" title="Number of restricted common shares issued">323,334 restricted common shares to an advisor. <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20260330__20260330__srt--TitleOfIndividualAxis__custom--AdvisorOneMember_zfgJ5eLnY0B3" title="Restricted common shares vested">83,334 restricted common shares vest immediately and the remaining balance vests in twelve months equal instalments. The restricted common shares had a fair value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20260330__20260330__srt--TitleOfIndividualAxis__custom--AdvisorOneMember_zKcdcoZXSokj" title="Fair value of restricted common shares issued">43,973. $11,332 was recognized as stock-based compensation during the period ended of March 31, 2026. As of March 31, 2026, the <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20260101__20260331__srt--TitleOfIndividualAxis__custom--AdvisorOneMember_zTwgBQFZCSoj" title="Restricted common shares vested">83,334 restricted common shares were fully vested. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. On November 10, 2025, the Company entered into a service agreement where the Company will grant the issuance of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20251110__20251110__srt--TitleOfIndividualAxis__custom--AdvisorTwoMember_zrnWaeH7Om9k" title="Number of restricted common shares issued">40,000 restricted common shares to the advisor on or before January 18, 2026. The Company granted the issuance of the restricted common shares on December 12, 2025. The restricted common shares were granted with a six month restriction period. The restricted common shares had a fair value of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20251110__20251110__srt--TitleOfIndividualAxis__custom--AdvisorTwoMember_zQ6iAfbagYd7" title="Fair value of restricted common shares issued">9,196. The Company recognized $4,598 as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20260101__20260331__srt--TitleOfIndividualAxis__custom--AdvisorTwoMember_zD8Qb1mVvvv7" title="Restricted common shares vested">0 restricted common shares were vested. On October 1, 2025, the Company granted the issuance of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20251001__20251001__srt--TitleOfIndividualAxis__custom--AdvisorThreeMember_zg7uj3EwtENi" title="Restricted common shares">120,000 restricted common shares to an advisor. The restricted common shares vest in twelve months equal instalments. The restricted common shares had a fair value of $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20251001__20251001__srt--TitleOfIndividualAxis__custom--AdvisorThreeMember_zO3G79YKn9u1" title="Fair value of restricted common shares issued">32,280. The Company recognized $8,070 as stock-based compensation during the period ended March 31, 2026. As of March 31, 2026, <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20260101__20260331__srt--TitleOfIndividualAxis__custom--AdvisorThreeMember_z3tOBrI4rA3" title="Restricted common shares vested">60,000 restricted common shares were vested. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. On December 1, 2024, the Company granted the issuance of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20241201__20241201__srt--TitleOfIndividualAxis__custom--AdvisorFourMember_zaMVrXPHwBW4" title="Restricted common shares">300,000 restricted common shares to an advisor. The restricted common shares vest in twelve months equal instalments. The restricted common shares had a fair value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20241201__20241201__srt--TitleOfIndividualAxis__custom--AdvisorFourMember_zvUboex8lfS7" title="Fair value of restricted common shares issued">141,000, of which was recognized as stock-based compensation in 2025. As of March 31, 2026, the <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20260101__20260331__srt--TitleOfIndividualAxis__custom--AdvisorFourMember_zVqquwMgJATk" title="Restricted common shares vested">300,000 restricted common shares were fully vested. As of March 31, 2026, the common shares were not issued to the equity holders and as such, the common shares were recorded as common stock liability on the statement of stockholder’s equity. Stock Warrants During the period ended March 31, 2026, the Company issued <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmIUsFWctZrh" title="Warrant issued">3,300,000 common stock warrants with exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrq5Jq4Hx5ch" title="Exercise price">0.08 in conjunction with convertible secured promissory notes agreements. The warrants had a relative fair value of $252,834, which was recorded as a discount on the note. The relative fair value of the warrants was estimated using a black-scholes model with the following assumptions: <p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfHiFzgizn15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Schedule of Fair Value of Warrants Estimated Using Black-Scholes Model <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSrPZdxDTZz8" title="Fair value of common stock on measurement date">0.12 per share</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Risk free interest rate (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zz6OfbJUnyIh" title="Risk free interest rate">4.08</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDIp_zYuW8uLKCl4f" title="Volatility">302.35</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDMp_zfGUPEYJJe8i" title="Dividend yield">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dtY_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbw7oH9Hg8P5" title="Warrants measurement input">5.00 years</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table> The following table summarizes the stock warrant activity for the three months ended March 31, 2026: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_za57ezKPPX7b" style="width: 16%; text-align: right" title="Warrants outstanding, beginning balance">6,350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVF4DLXtEnha" style="width: 16%; text-align: right" title="Weighted average exercise price per share, beginning balance">0.15</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z70tiVkrJrVc" style="text-align: right" title="Warrants outstanding, granted">3,300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAFFMsAB9O13" style="text-align: right" title="Weighted average exercise price per share, granted">0.08</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGxPhyz9C6v9" style="text-align: right" title="Warrants outstanding, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zforadz0pHSe" style="text-align: right" title="Weighted average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvA3lwousuM9" style="text-align: right" title="Warrants outstanding, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zK0I8iZlsy01" style="text-align: right" title="Weighted average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfhjffmDHYV8" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwOVmNb0y5T8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqSFs4arlH24" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">9,650,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlIpyoJjnCL5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">0.12</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of March 31, 2026 the outstanding and exercisable warrants have a weighted average remaining term of <span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerms_dtY_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zYTXvsBAzKOe" title="Warrants outstaning and exercisable, weighted average remaining term">4.29 with no intrinsic value. Stock Options On February 23, 2026, the Company issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zVELBIoBBO18" title="Stock options, issuance">450,000 options to employees. The options issued have a <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zUZ1ntrL4iAl" style="display: none" title="Options term">1one-year term at an exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z8c1a9BvoH7a" title="Options exercise price">0.18. The options issued to the employees vest immediately on the date of issuance. The total fair value of these option grants at issuance was $<span id="xdx_907_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationGross_pid_c20260223__20260223__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_z4EZXdS2CMz1" title="Fair value of option granted">15,988. The Company valued the stock options using the Black-Scholes model with the following key assumptions: <p id="xdx_899_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zVTuKDSdRMR" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: justify">Schedule of Stock Options Assumptions <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGwuihHYrAje" title="Fair value of common stock on measurement date">0.16 per share</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Risk free interest rate (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90A_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_z9XAUTw79VZ" title="Risk free interest rate">3.50</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDIp_zpN0iP33ByG2" title="Volatility">67.73</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zaHMXPNYtPTc" title="Dividend yield">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_dtY_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkMIRWHcF1u7" title="Options measurement input">0.9 years</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table> During the three months ended March 31, 2026, the Company recognized $106,555 of expense related to outstanding stock options. The following table summarizes the stock option activity for the three months ended March 31, 2026: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGPJtHwUJrd3" style="width: 16%; text-align: right" title="Options outstanding, Balance">5,465,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_z32g17WjX6t1" style="width: 16%; text-align: right" title="Weighted average exercise price, Balance">0.41</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8zgLbqYllC3" style="text-align: right" title="Options outstanding, Granted">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z04zG0zm9LTb" style="text-align: right" title="Weighted average exercise price, Granted">0.18</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zxzXeKOrUaNk" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zK5Ux2PddWYb" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z15odV39eAga" style="text-align: right" title="Options outstanding, Forfeited">(550,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGsSgZTMWsK5" style="text-align: right" title="Weighted average exercise price, Forfeited">0.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNoxVgGeA3r" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHzPUTwNxDia" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zWURn9FzHkSc" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance">5,365,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zVKzjwKBWGD1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Balance">0.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zpx53lpbw2x9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable, Balance">3,113,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znnvRom4Sqd3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercisable, Balance">0.36</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of March 31, 2026, the outstanding and exercisable options have a weighted average remaining term of <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhWNBrppzop" title="Weighted average remaining term outstanding"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zefZSHrd3Ny" title="Weighted average remaining term, exercisable">3.87 with an intrinsic value of $<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGlRinPCoRHi" title="Exercisable, intrinsic value">0.

500000000

0.001

50000000

0.001

38890943

2068

0.001

Each share of Series A has voting rights equal to the amount of shares of common stock into which the Series A is convertible. Each share of Series A is convertible on a 1 to 1.25 common share basis.

2068

8619420

0.001

Each share of Series B-1 has voting rights 3.2x (times) that of the number of votes that is equal to the number of common stock into which the Series B-1 are convertible.

Each share of Series B-1 is convertible on a 1 to 11 common share basis.

0.51

8619420

4309710 307647

0.605

0.66

0.055

0.06

100000

150000

700000 950000

800000

0.13

1129920

3107438

0.001

4722224

650000

50000

4722224

650000

516000

81364

516000

81364

100000

10696

5304

100000

10696

40000

5528

1110238

181993

10000

30000

4509

7000

21000

3156

7000

14000

35000

42000

6313

7000

35000

21000

3156

1264238

204656

8830462

323334

83334

43973

11332

83334

40000

9196

4598

120000

32280

8070

60000

300000

141000

300000

3300000

0.08

252834

<p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zfHiFzgizn15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Schedule of Fair Value of Warrants Estimated Using Black-Scholes Model <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSrPZdxDTZz8" title="Fair value of common stock on measurement date">0.12 per share</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Risk free interest rate (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDEp_zz6OfbJUnyIh" title="Risk free interest rate">4.08</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDIp_zYuW8uLKCl4f" title="Volatility">302.35</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_fKDMp_zfGUPEYJJe8i" title="Dividend yield">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_dtY_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbw7oH9Hg8P5" title="Warrants measurement input">5.00 years</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table>

0.12

4.08

302.35

5.00

The following table summarizes the stock warrant activity for the three months ended March 31, 2026: Schedule of Warrant Outstanding <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_za57ezKPPX7b" style="width: 16%; text-align: right" title="Warrants outstanding, beginning balance">6,350,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zVF4DLXtEnha" style="width: 16%; text-align: right" title="Weighted average exercise price per share, beginning balance">0.15</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z70tiVkrJrVc" style="text-align: right" title="Warrants outstanding, granted">3,300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAFFMsAB9O13" style="text-align: right" title="Weighted average exercise price per share, granted">0.08</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zGxPhyz9C6v9" style="text-align: right" title="Warrants outstanding, exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zforadz0pHSe" style="text-align: right" title="Weighted average exercise price per share, exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvA3lwousuM9" style="text-align: right" title="Warrants outstanding, forfeited">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zK0I8iZlsy01" style="text-align: right" title="Weighted average exercise price per share, forfeited">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfhjffmDHYV8" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredWeightedAverageGrantDateFairValue_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwOVmNb0y5T8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price per share, expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zqSFs4arlH24" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">9,650,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlIpyoJjnCL5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price per share, ending balance">0.12</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

6350000

0.15

3300000

0.08

9650000

0.12

P4Y3M14D

450000

P1Y

0.18

15988

<p id="xdx_899_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zVTuKDSdRMR" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt; text-align: justify">Schedule of Stock Options Assumptions <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Period Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of common stock on measurement date</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGwuihHYrAje" title="Fair value of common stock on measurement date">0.16 per share</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Risk free interest rate (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90A_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_z9XAUTw79VZ" title="Risk free interest rate">3.50</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Volatility (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDIp_zpN0iP33ByG2" title="Volatility">67.73</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zaHMXPNYtPTc" title="Dividend yield">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_dtY_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zkMIRWHcF1u7" title="Options measurement input">0.9 years</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The trading volatility was determined by calculating the volatility of the Company’s peer group.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company does not expect to pay a dividend in the foreseeable future.</td></tr> </table>

0.16

3.50

67.73

0.9

106555

The following table summarizes the stock option activity for the three months ended March 31, 2026: Schedule of Stock Options <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted-Average Exercise Price Per Share</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGPJtHwUJrd3" style="width: 16%; text-align: right" title="Options outstanding, Balance">5,465,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDEp_z32g17WjX6t1" style="width: 16%; text-align: right" title="Weighted average exercise price, Balance">0.41</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8zgLbqYllC3" style="text-align: right" title="Options outstanding, Granted">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z04zG0zm9LTb" style="text-align: right" title="Weighted average exercise price, Granted">0.18</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zxzXeKOrUaNk" style="text-align: right" title="Options outstanding, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zK5Ux2PddWYb" style="text-align: right" title="Weighted average exercise price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z15odV39eAga" style="text-align: right" title="Options outstanding, Forfeited">(550,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGsSgZTMWsK5" style="text-align: right" title="Weighted average exercise price, Forfeited">0.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zNoxVgGeA3r" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zHzPUTwNxDia" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_uShares_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_fKDMp_zWURn9FzHkSc" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, Balance">5,365,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zVKzjwKBWGD1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Balance">0.38</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable, March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zpx53lpbw2x9" style="border-bottom: Black 2.5pt double; text-align: right" title="Options exercisable, Balance">3,113,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_znnvRom4Sqd3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercisable, Balance">0.36</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

5465000

0.41

450000

0.18

550000

0.51

5365000

0.38

3113750

0.36

P3Y10M13D

Note 8: Commitments In December 2024, The Company entered into an employment agreement with Mr. Leal, of which will become effective as of the effective date of the registration statement on Form S-1 in connection with the Company’s planned public offering of its shares. Pursuant to the employment agreements, Mr. Leal has agreed to serve as Chief Executive Officer and as a Director for five years from the effective date in consideration for an annualized salary of $300,000, payable in regular instalments in accordance with the usual payment practices of the Company. The employment agreements contemplate annual bonus awards based on the achievement of performance objectives and targets established annually by the Board of Directors and possible additional bonuses for services and results achieved by Mr. Leal. On July 22, 2025, the Company entered into an Independent Software Vendor Program Agreement (the “Agreement”) with Five9, Inc. (“Five9”), a Delaware corporation. Five9 is a leading provider of intelligent cloud software and applications for contact centers. Pursuant to the Agreement, Five9 granted the Company a non-exclusive, worldwide, royalty-free, non-sublicensable and non-transferable license to access the Five9 developer account with the purpose of integrating the Company’s products and services and becoming an accredited vendor under Five9’s ISV program. The Company has agreed to pay a non-refundable ISV Program participation fee to Five9 for the initial one-year term of the Agreement and for each one-year renewal term thereafter. Further, each party to the Agreement may receive referral fees from the other party for the referral of prospective customers. On August 22, 2025, the Company entered into a Genesys AppFoundery ISV Partner Agreement with Genesys Cloud Services, Inc. (“Genesys”), a California corporation. Genesys manages the Genesys AppFoundry, a marketplace of solutions that offers Genesys customers a curated selection of integrations and applications. The agreement governs the Company’s non-exclusive participation as an AppFoundry ISV Partner in the Genesys AppFoundry Program. The Company has agreed to pay a non-refundable revenue share to Genesys during the term of the Agreement based on a percentage of the revenue invoiced by the Company or Genesys in connection with the sale of the Company’s software through the AppFoundry marketplace. The agreement may be terminated by either party without cause upon ninety (90) days written notice to the other party.

300000

Note 9: Subsequent Events On April 8, 2026, the Company entered into a Master Reseller Agreement (the “Reseller Agreement”) for an initial term of three-years. Upon execution of the agreement, the Company received $<span id="xdx_90B_eus-gaap--DeferredRevenue_iI_c20260408__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MasterResellerAgreementMember_zQoeGCyTeRu6" title="Credit balance for future service">3,000,000 as a credit balance for future service. In connection with the Reseller Agreement, the Company granted the issuance of a <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260408__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MasterResellerAgreementMember_zAcxxa7mxavb" style="display: none" title="Warrants term">10 ten-year warrant to purchase a number of shares of common stock having a value of $<span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstanding_iI_c20260408__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--MasterResellerAgreementMember_zYhX429gsWAd" title="Warrants issued value">3,000,000. The warrant amount will be based on the day volume weighted average price of the common stock during the 30-day period ending on the day prior to the execution of the warrant. As of April 10, 2026, the Company purchased <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_c20260410__20260410__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_ztIQqqfFMKdd" title="Number of shares purchased">4,166,667 shares of the Company’s Series B-1 Preferred Stock held by Rowland at a price of $<span id="xdx_901_eus-gaap--SharePrice_iI_c20260410__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zwaoXzSj6yPg" title="Share price">0.66 per Series B-1 Preferred share for a total cash consideration of $<span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodValue_c20260410__20260410__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBOnePreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RowlandDayMember_zVdkfOjOlP45" title="Cash consideration">2,850,000. On April 7, 2026, the Company defaulted on the March 26, 2026 Secured Promissory Notes. The Company granted the issuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesOther_c20260407__20260407__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--SecuredPromissoryNotesMember_zso3diD95KM2" title="Shares issued for failure to pay principal and accrued interest">8,750,000 common stock shares to the holders for failure to pay the principal and accrued interest on the maturity date.

3000000

P10Y

3000000

4166667

0.66

2850000

8750000

false false false false The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date. The trading volatility was determined by calculating the volatility of the Company’s peer group. The Company does not expect to pay a dividend in the foreseeable future. The risk-free interest rate was determined by management using the market yield on U.S. Treasury securities with comparable terms as of the measurement date. The trading volatility was determined by calculating the volatility of the Company’s peer group. The Company does not expect to pay a dividend in the foreseeable future.